Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
The goal of this interventional study is to learn if TRIV-509 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-509. Participants will receive 4 doses of the study intervention that they are randomized to (TRIV-509 or placebo), and at Week 16 will cross over and receive 4 doses of the other study intervention. The study duration for individual participants is up to 57 weeks, including a Screening period of up to 30 days.
Sponsor: Triveni Bio
Check if you qualify for this atopic dermatitis clinical trial in Pittsburgh, PA
If you're searching for atopic dermatitis treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.